STAT3 and neoplasm: c-MET signaling in the presence of its ligand HGF controls tumor growth and invasiveness by activating MAPK/ERK cascades, PI3K/Akt axis, STAT3 pathway, and/or NF-κB inhibitor-α kinase (IKK)—NF-κB complex [116,117,118].